Clinical Trial Design in Ulcerative Colitis: Interpreting Evolving Endpoints Based on Post Hoc Analyses of the Vedolizumab Phase 3 Trials GEMINI 1 and VISIBLE 1.
| Autor: | Sandborn, William J, Sands, Bruce E, Uddin, Sharif, Khan, Rana M Qasim, Mukherjee, Richa Sagar |
|---|---|
| Zdroj: | Crohn's & Colitis 360; Jan2024, Vol. 6 Issue 1, p1-5, 5p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|